Strategic Alliance: French Pharmaceutical Group Partners with Major Drugstore Chain
Boosting the supply of European-standard healthcare products in the Vietnamese market
A reputable pharmaceutical corporation from France, with over seven decades of experience in the research, production, and distribution of healthcare products, has announced the signing of a comprehensive cooperation agreement with a leading retail drugstore chain in Vietnam. The strategic signing event took place on the morning of December 03, 2025.
Rising Demand for International Standard Healthcare
The partnership occurs against the backdrop of Vietnamese consumers increasingly focusing on holistic health, prioritizing prevention, and quality of life improvement, particularly concerning digestive health and the immune system. This trend fuels the demand for healthcare products with transparent origins, scientifically proven efficacy, and adherence to international quality standards. Pharmaceutical products from Europe, notably France, are highly trusted due to their strict quality control procedures.
The market reveals significant potential for specialized, safe, and sustainable healthcare solutions, addressing practical needs such as digestive support for children, immune enhancement, physiological cycle care for women, and chronic pain management for the elderly. The official presence of major French pharmaceutical enterprises is expected to contribute to the modernization and personalization of Vietnam’s healthcare sector.
Comprehensive Cooperation to Ensure Quality
The strategic agreement between the two entities will focus on enhancing the distribution of healthcare products manufactured by the French Group under European standards, utilizing the retail partner’s extensive nationwide pharmacy network.
The representative of the French Group expressed confidence that this partnership with an influential pharmaceutical retail chain in Vietnam will double their strength in delivering high-quality products to the Vietnamese people.
Meanwhile, the retail chain’s representative emphasized that, as a market leader, their mission is not only to supply genuine medicines but also to make strategic investments in programs that raise awareness about nutrition and sustainable living. The core objective is to empower consumers to be more proactive and comprehensive in their self-care.
Stature and Foundations of the Involved Parties
The French Pharmaceutical Group, through its Vietnam subsidiary established in 2025, is executing a strategic expansion into Asia. The Group is a global leader in probiotics, particularly known for the Saccharomyces boulardii CNCM I-745 strain. The Vietnamese subsidiary’s mission is to bring international-standard microbiome health solutions closer to the Vietnamese population.
The Vietnamese Retail Drugstore Chain, with over 13 years of development, has solidified its leading position in the pharmaceutical retail market. The company operates a network of over 1,000 GPP-standard drugstores across 42 provinces and cities, supported by a team of nearly 5,000 highly qualified pharmacists, committed to providing dedicated health care services and convenient shopping experiences for all customers.
